As of Jan 17
| +1.01 / +2.07%|
The 6 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 45.00, with a high estimate of 52.00 and a low estimate of 40.00. The median estimate represents a -9.69% decrease from the last price of 49.83.
The current consensus among 6 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.